Douglas S. Ingram's Insider Trades & SAST Disclosures
Douglas S. Ingram's most recent trade in Arrowhead Pharmaceuticals Inc. was a trade of 38,396 Common Stock done at an average price of $20.1 . Disclosure was reported to the exchange on Feb. 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Douglas S. Ingram.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals ... | Douglas S. Ingram | Director | Grant, award, or other acquisition of securities at price $ 20.09 per share. | 06 Feb 2025 | 38,396 | 38,396 (0%) | 0% | 20.1 | 771,376 | Common Stock |
| Relay Therapeutics Inc | Douglas S. Ingram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 102,225 | 102,225 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Douglas S. Ingram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 66,055 | 66,055 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Douglas S. Ingram | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 41,597 | 41,597 | - | - | Stock Option (Right to Buy) | |
| Sarepta Therapeutics Inc | Douglas S. Ingram | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 79.94 per share. | 17 Nov 2021 | 25,026 | 365,082 (0%) | 0% | 79.9 | 2,000,578 | Common Stock |
| Sarepta Therapeutics Inc | Douglas S. Ingram | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.40 per share. | 26 Jun 2021 | 17,812 | 340,056 (0%) | 0% | 80.4 | 1,432,085 | Common Stock |
| Relay Therapeutics Inc | Douglas S. Ingram | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 20 Jul 2020 | 25,000 | 25,000 | - | 20 | 500,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges